Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Interest & Investment Income of $3.7 million in Q3 2025, up 7.49% quarter-over-quarter from $3.4 million in Q2 2025, and up 73.86% on a YoY basis from $2.1 million in Q3 2024.
Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $3.7 million for Q3 2025.
- In Q3 2025, Interest & Investment Income rose 73.86% year-over-year to $3.7 million; the TTM figure through Sep 2025 stood at $14.8 million (up 18.38% YoY), while the FY2024 annual figure was $17.4 million, up 264.5% from the prior year.
- Interest & Investment Income was $3.7 million for Q3 2025 at Dianthus Therapeutics, up from $3.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.3 million in Q2 2024 to a low of $416000.0 in Q3 2022.
- Historically, Interest & Investment Income has averaged $1.9 million across 5 years, with a median of $1.0 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income sank 49.14% in 2022, then soared 523.87% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $848000.0 in 2021, then decreased by 24.53% to $640000.0 in 2022, then jumped by 281.88% to $2.4 million in 2023, then soared by 63.26% to $4.0 million in 2024, then retreated by 8.32% to $3.7 million in 2025.
- The last three Interest & Investment Income figures came in at $3.7 million (Q3 2025), $3.4 million (Q2 2025), and $3.8 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.66 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 687,000.00 |
| Mar 31, 2023 | 606,000.00 |
| Dec 31, 2022 | 640,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 812,000.00 |
| Mar 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 848,000.00 |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | 682,000.00 |
| Mar 31, 2021 | 1.21 Mn |
| Dec 31, 2020 | 897,000.00 |